0000899243-20-019904.txt : 20200721
0000899243-20-019904.hdr.sgml : 20200721
20200721195401
ACCESSION NUMBER: 0000899243-20-019904
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200721
FILED AS OF DATE: 20200721
DATE AS OF CHANGE: 20200721
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pons Jaume
CENTRAL INDEX KEY: 0001816977
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39386
FILM NUMBER: 201039978
MAIL ADDRESS:
STREET 1: C/O ALX ONCOLOGY HOLDINGS INC.
STREET 2: 866 MALCOLM ROAD, SUITE 100
CITY: BURLINGAME
STATE: CA
ZIP: 94010
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ALX ONCOLOGY HOLDINGS INC
CENTRAL INDEX KEY: 0001810182
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 850642577
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 866 MALCOLM ROAD, SUITE 100
CITY: BURLINGAME
STATE: CA
ZIP: 94010
BUSINESS PHONE: 650-466-7125
MAIL ADDRESS:
STREET 1: 866 MALCOLM ROAD, SUITE 100
CITY: BURLINGAME
STATE: CA
ZIP: 94010
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-07-21
0
0001810182
ALX ONCOLOGY HOLDINGS INC
ALXO
0001816977
Pons Jaume
C/O ALX ONCOLOGY HOLDINGS INC.
866 MALCOLM ROAD, SUITE 100
BURLINGAME
CA
94010
1
1
0
0
President and CEO
Common Stock
2020-07-21
4
C
0
27292
A
541346
D
Series A Convertible Preferred Stock
2020-07-21
4
C
0
20225
D
Common Stock
20225
0
D
Series A Convertible Preferred Stock
2020-07-21
4
C
0
1803
D
Common Stock
1803
0
D
Series C Convertible Preferred Stock
2020-07-21
4
C
0
5264
D
Common Stock
5264
0
D
Each share of Series A Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date.
Each share of Series B Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date.
Each share of Series C Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date.
Includes 4,982 shares of Common Stock issued as payment of accrued dividends upon conversion of the preferred stock on July 21, 2020.
/s/ Peter Garcia, by power of attorney
2020-07-21